Market Tracker

07/24 3:18pm ET

Avanir Pharmaceuticals Inc (NASDAQ:AVNR)

5.28
Real-Time Quote
 -0.085 / -1.59%
Today’s Change
2.62
Today|||52-Week Range
6.00
+56.99%
Year-to-Date

Today’s Trading

Previous close5.36
Today’s open5.36
Day’s range5.26 - 5.44
Volume672,967
Average volume (3 months)2,956,102
Market cap$917.0M
Dividend yield--
Data as of 3:03pm ET, 07/24/2014

Growth & Valuation

Earnings growth (last year)-17.78%
Earnings growth (this year)+41.51%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)+82.59%
P/E ratioNM
Price/Sales--
Price/Book44.13

Competitors

 Today’s
change
Today’s
% change
INSYInsys Therapeutics I...-0.02-0.07%
EBSEmergent BioSolution...-0.49-2.10%
SRPTSarepta Therapeutics...-0.89-4.17%
USNAUSANA Health Science...-0.66-0.94%
Data as of 3:17pm ET, 07/24/2014

Financials

Next reporting dateAugust 5, 2014
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$75.4M
Annual profit (last year)-$75.5M
Net profit margin-100.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Keith A. Katkin
Secretary &
Vice President-Finance
Christine G. Ocampo
Corporate headquarters
Aliso Viejo, California

Forecasts